Do you want to read an article? Please log in or register.
Time for a New Standard: Single Agent Ibrutinib shows Long-Term Efficacy and Safety in Previously Treated MCL and CLL1-4
LeukemiaLymphoma
Related content
LeukemiaLymphoma
Single-Agent Ibrutinib is Effective and Well Tolerated in Treatment-Naïve CLL and R/R MCL1-4
This healthbook SPECIAL is supported by Janssen-Cilag AG
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
SPECIAL REPORT
Multiple Myeloma (MM)
Traitement du myélome multiple récidivant/réfractaire
SPECIAL REPORT
Multiple Myeloma (MM)
Therapie des rezidivierten/refraktären Multiplen Myeloms
SPECIAL REPORT
Skin Cancer
Bavencio® (Avelumab): Treatment for Metastatic Merkel Cell Carcinoma1,2
Lymphoma
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Lancet Oncol.
Locke FL, Ghobadi A, Jacobson CA, Miklos DB, Lekakis LJ, Oluwole OO, Lin Y, Braunschweig I, Hill BT, Timmerman JM, Deol A, Reagan PM, Stiff P, Flinn IW, Farooq U, Goy A, McSweeney PA, Munoz J, Siddiqi T, Chavez JC, Herrera AF, Bartlett NL, Wiezorek JS, Navale L, Xue A, Jiang Y, Bot A, Rossi JM, Kim JJ, Go WY, Neelapu SS
doi: 10.1016/S1470-2045(18)30864-7.
Endocrine and Neuroendocrine Tumors (NET)
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
Lancet Oncol
Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC, Pavel ME, Grande E, Van Cutsem E, Seregni E, Duarte H, Gericke G, Bartalotta A, Mariani MF, Demange A, Mutevelic S, Krenning EP, NETTER-1 investigators.
doi: 10.1016/S1470-2045(21)00572-6
Folate Receptor α: A New Target for an Old Enemy?
★ 3
Recommended by
Alexander Meisel, Faculty Member
1Brustzentrum St.Gallen, Kantonsspital St.Gallen, St.Gallen, Switzerland
Breast Cancer
Breast Cancer Treatment in the Era of Precision Medicine
1Breast Cancer Center, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland